Back to News
Market Impact: 0.3

Pre-Market Earnings Report for October 9, 2025 : PEP, DAL, TLRY, NEOG, HELE, BYRN

PEPDALTLRYNEOGHELEBYRNNDAQ
Corporate EarningsAnalyst EstimatesCompany Fundamentals
Pre-Market Earnings Report for October 9, 2025 :  PEP, DAL, TLRY, NEOG, HELE, BYRN

Several companies are slated to report earnings on October 9, 2025, revealing a mixed financial outlook. Pepsico (PEP) is projected for a slight year-over-year EPS decline but carries a premium P/E ratio, indicating higher growth expectations relative to its industry, while Delta Air Lines (DAL) anticipates modest EPS growth. Conversely, Helen of Troy (HELE) is forecast for a substantial 65.31% EPS decrease following recent misses, contrasting with Byrna Technologies (BYRN), which expects a 25% EPS increase and has consistently beaten estimates, reflected in its significantly higher P/E multiple.

Analysis

The following companies are expected to report earnings prior to market open on 10/09/2025. Visit our Earnings Calendar for a full list of expected earnings releases. Pepsico, Inc. (PEP)is reporting for the quarter ending September 30, 2025. The beverages company's consensus earnings per share forecast from the 8 analysts that follow the stock is $2.27. This value represents a 1.73% decrease compared to the same quarter last year. PEP missed the consensus earnings per share in the 1st calendar quarter of 2025 by -1.33%. Zacks Investment Research reports that the 2025 Price to Earnings ratio for PEP is 17.53 vs. an industry ratio of 4.30, implying that they will have a higher earnings growth than their competitors in the same industry. Delta Air Lines, Inc. (DAL)is reporting for the quarter ending September 30, 2025. The airline company's consensus earnings per share forecast from the 8 analysts that follow the stock is $1.52. This value represents a 1.33% increase compared to the same quarter last year. DAL missed the consensus earnings per share in the 3rd calendar quarter of 2024 by -3.85%. Zacks Investment Research reports that the 2025 Price to Earnings ratio for DAL is 9.99 vs. an industry ratio of 10.90. Tilray Brands, Inc. (TLRY)is reporting for the quarter ending August 31, 2025. The medical products company's consensus earnings per share forecast from the 3 analysts that follow the stock is $-0.03. This value represents a 25.00% increase compared to the same quarter last year. Zacks Investment Research reports that the 2026 Price to Earnings ratio for TLRY is -15.55 vs. an industry ratio of 7.60. Neogen Corporation (NEOG)is reporting for the quarter ending August 31, 2025. The medical products company's consensus earnings per share forecast from the 1 analyst that follows the stock is $0.03. This value represents a 57.14% decrease compared to the same quarter last year. Zacks Investment Research reports that the 2026 Price to Earnings ratio for NEOG is 22.36 vs. an industry ratio of 7.60, implying that they will have a higher earnings growth than their competitors in the same industry. Helen of Troy Limited (HELE)is reporting for the quarter ending August 31, 2025. The cosmetic & toiletries company's consensus earnings per share forecast from the 3 analysts that follow the stock is $0.34. This value represents a 65.31% decrease compared to the same quarter last year. The last two quarters HELE had negative earnings surprises; the latest report they missed by -42.03%. Zacks Investment Research reports that the 2026 Price to Earnings ratio for HELE is 6.79 vs. an industry ratio of 32.70. Byrna Technologies, Inc. (BYRN)is reporting for the quarter ending August 31, 2025. The technology services company's consensus earnings per share forecast from the 2 analysts that follow the stock is $0.05. This value represents a 25.00% increase compared to the same quarter last year. In the past year BYRN has beat the expectations every quarter. The highest one was in the 2nd calendar quarter where they beat the consensus by 100%. Zacks Investment Research reports that the 2025 Price to Earnings ratio for BYRN is 64.60 vs. an industry ratio of 15.00, implying that they will have a higher earnings growth than their competitors in the same industry. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Pepsico (PEP) is projected to report Q3 2025 EPS of $2.27, reflecting a 1.73% year-over-year decrease, following a 1.33% miss in Q1 2025. Despite this, its 2025 P/E ratio of 17.53, significantly higher than the industry's 4.30, suggests an analyst expectation for robust future earnings growth. Delta Air Lines (DAL) is expected to show a modest 1.33% year-over-year EPS increase to $1.52 for Q3 2025, although it previously missed Q3 2024 consensus by 3.85%. Conversely, Helen of Troy (HELE) faces significant headwinds, with a forecasted 65.31% year-over-year EPS decrease to $0.34 for Q1 2025, compounded by missing consensus by 42.03% in the prior quarter and negative surprises in the last two. Neogen (NEOG) is also anticipated to report a substantial 57.14% year-over-year EPS decrease to $0.03, despite its P/E ratio of 22.36 against an industry 7.60 implying higher growth. Tilray Brands (TLRY) is projected for a negative EPS of $-0.03, albeit a 25% increase from last year, with a negative 2026 P/E of -15.55. Byrna Technologies (BYRN) presents a strong counter-narrative, with a projected 25.00% year-over-year EPS increase to $0.05 for Q1 2025. The company has a track record of consistently beating expectations in the past year, including a 100% beat in Q2 2024, and its elevated 2025 P/E ratio of 64.60 versus an industry 15.00 signals high growth prospects and investor confidence in its outlook.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mixed

Sentiment Score

-0.10

Ticker Sentiment

BYRN0.70
DAL0.10
HELE-0.70
NDAQ0.00
NEOG-0.20
PEP0.20
TLRY-0.30

Key Decisions for Investors

  • Investors should closely monitor the actual earnings releases for PEP and DAL to validate their respective growth trajectories and P/E justified valuations.
  • Consider exercising caution or re-evaluating positions in HELE given its significant projected EPS decrease and consistent misses in recent quarters.